Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001062101 | SCV001226877 | pathogenic | Ocular cystinosis; Juvenile nephropathic cystinosis; Nephropathic cystinosis | 2019-07-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr281Leufs*15) in the CTNS gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with CTNS-related conditions. Loss-of-function variants in CTNS are known to be pathogenic (PMID: 9537412, 27102039). For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV001266858 | SCV001445038 | pathogenic | Inborn genetic diseases | 2020-01-31 | criteria provided, single submitter | clinical testing |